UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Transvaginal Sperm Intra-Fallopian Transfer (SIFT)

Acta obstetricia et gynecologica Scandinavica, 1988-01, Vol.67 (5), p.471-472

1988

Volltextzugriff (PDF)

Transvaginal Sperm Intra-Fallopian Transfer (SIFT): A new treatment for unexplained infertility

Acta obstetricia et gynecologica Scandinavica, 1988, Vol.67 (5), p.471-472

1988

Volltextzugriff (PDF)

Plasma concentrations of motilin and somatostatin are increased in late pregnancy and postpartum

BJOG : an international journal of obstetrics and gynaecology, 1992-04, Vol.99 (4), p.338-341

1992

Volltextzugriff (PDF)

Experience with GnRH agonists in an in vitro fertilization (IVF) program

Acta obstetricia et gynecologica Scandinavica, 1991, Vol.70 (4-5), p.339-342

1991

Volltextzugriff (PDF)

Proteomics reveals the effects of sustained weight loss on the human plasma proteome

Molecular systems biology, 2016-12, Vol.12 (12), p.901-n/a

2016

Volltextzugriff (PDF)

Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease

Molecular systems biology, 2019-03, Vol.15 (3), p.e8793-n/a

2019

Volltextzugriff (PDF)

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

Diabetes, obesity & metabolism, 2022-10, Vol.24 (10), p.2017-2026

2022

Volltextzugriff (PDF)

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Diabetes, obesity & metabolism, 2021-09, Vol.23 (9), p.2009-2019

2021

Volltextzugriff (PDF)

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Diabetes, obesity & metabolism, 2022-06, Vol.24 (6), p.1182-1184

2022

Volltextzugriff (PDF)

On the relationship between glucose absorption and glucose‐stimulated secretion of GLP‐1, neurotensin, and PYY from different intestinal segments in the rat

Physiological reports, 2017-12, Vol.5 (23), p.n/a

2017

Volltextzugriff (PDF)

No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial

Diabetes, obesity & metabolism, 2021-02, Vol.23 (2), p.530-539

2021

Volltextzugriff (PDF)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors

Physiological reports, 2017-12, Vol.5 (23), p.n/a

2017

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

Hepatology communications, 2020-11, Vol.4 (11), p.1610-1623

2020

Volltextzugriff (PDF)

No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes

Diabetes, obesity & metabolism, 2020-10, Vol.22 (10), p.1837-1846

2020

Volltextzugriff (PDF)

Effects of simulated sample sizes on the mortality effect estimates in three randomized intensive care unit trials

Acta anaesthesiologica Scandinavica, 2020-08, Vol.64 (7), p.976-981

2020

Volltextzugriff (PDF)

External validation of the Simplified Mortality Score for the Intensive Care Unit (SMS‐ICU)

Acta anaesthesiologica Scandinavica, 2019-10, Vol.63 (9), p.1216-1224

2019

Volltextzugriff (PDF)

Acute administration of interleukin‐6 does not increase secretion of glucagon‐like peptide‐1 in mice

Physiological reports, 2018-07, Vol.6 (13), p.e13788-n/a

2018

Volltextzugriff (PDF)

Do sodium-glucose transporter-2 inhibitors increase plasma glucagon by direct actions on the alpha-cell? - and does the increase matter for the associated increase in endogenous glucose production?

Diabetes, obesity & metabolism, 2021-05

2021

Volltextzugriff (PDF)

Cover Image, Volume 22, Issue 10

Diabetes, obesity & metabolism, 2020-10, Vol.22 (10)

2020

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Glucagon
(9)
Humans
(7)
Female
(6)
Diabetes
(5)
Endocrinology & Metabolism
(5)
Insulin
(5)
Obesity
(5)
Peptides
(5)
Plasma
(5)
Animals
(4)
Body Mass Index
(4)
Diabetes Mellitus
(4)
Glucose
(4)
Male
(4)
Type 2 Diabetes
(4)
Biological And Medical Sciences
(3)
Glucagon-Like Peptide 1 - Metabolism
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid
(14)
Wiley Online Library Full Collection 2018
(13)
MEDLINE
(10)
EZB Electronic Journals Library
(9)
Taylor & Francis Online
(3)
Taylor & Francis Journals
(3)
Ingenta
(1)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transvaginal Sperm Intra-Fallopian Transfer (SIFT)

Transvaginal Sperm Intra-Fallopian Transfer (SIFT): A new treatment for unexplained infertility

Plasma concentrations of motilin and somatostatin are increased in late pregnancy and postpartum

Experience with GnRH agonists in an in vitro fertilization (IVF) program

Proteomics reveals the effects of sustained weight loss on the human plasma proteome

Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease

Acute effects on glucose tolerance by neprilysin inhibition in patients with type 2 diabetes

Do sodium‐glucose co‐transporter‐2 inhibitors increase plasma glucagon by direct actions on the alpha cell? And does the increase matter for the associated increase in endogenous glucose production?

Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

On the relationship between glucose absorption and glucose‐stimulated secretion of GLP‐1, neurotensin, and PYY from different intestinal segments in the rat

No effects of dapagliflozin, metformin or exercise on plasma glucagon concentrations in individuals with prediabetes: A post hoc analysis from the randomized controlled PRE‐D trial

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors

Nonalcoholic Fatty Liver Disease Impairs the Liver–Alpha Cell Axis Independent of Hepatic Inflammation and Fibrosis

No effects of a 6‐week intervention with a glucagon‐like peptide‐1 receptor agonist on pancreatic volume and oedema in obese men without diabetes

Effects of simulated sample sizes on the mortality effect estimates in three randomized intensive care unit trials

External validation of the Simplified Mortality Score for the Intensive Care Unit (SMS‐ICU)

Acute administration of interleukin‐6 does not increase secretion of glucagon‐like peptide‐1 in mice

Do sodium-glucose transporter-2 inhibitors increase plasma glucagon by direct actions on the alpha-cell? - and does the increase matter for the associated increase in endogenous glucose production?

Cover Image, Volume 22, Issue 10

Aktive Filter

Suchergebnisse filtern